


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 23 May 2025
England's NICE Recommends FILSPARI(R) (sparsentan) as a Treatment Option for IgA Nephropathy
England's NICE Recommends FILSPARI(R) (sparsentan) as a Treatment Option for IgA Nephropathy
HSMN NewsFeed - 1 Apr 2025
Zimmer Biomet Receives CE Mark Approval for RibFix Advantage(R) Fixation System
Zimmer Biomet Receives CE Mark Approval for RibFix Advantage(R) Fixation System
